CGON: CG Oncology Corp Revenue Growth QoQ

CG Oncology Corp (CGON) - corporate logo

CG Oncology, Inc. (CGON) operates on internal biotechnological cycles, rendering the business independent of external market fluctuations. The quarterly sales growth rate illustrates this trend, where the -3.80 level represents the current value. Stability is driven by the integration of bladder cancer therapy into clinical protocols, while unique oncolytic viruses provide opportunities for premium pricing power within its segment.

CGON CG Oncology Inc Sales Growth QoQ (02/21/2024 - 11/21/2026)

Analytical breakdowns and data insights for company CG Oncology Inc (CGON)

- share price and expert price forecast:
Fundamental company valuation:CGON - CG Oncology Inc
Mass-produced product of CG Oncology

Quarterly revenue growth measures the percentage change in operating income compared to the same period last year, allowing for an assessment of the business's recovery speed and its resilience to external shocks. By analyzing the quarterly revenue growth rate, an investor can confirm the commercial effectiveness of the oncolytic virus development at CG Oncology, Inc. (CGON), whose patents for bladder cancer therapy provide a long-term market advantage.

Main competitors

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|Revolution Medicines Corp (RVMD) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Ascentage Pharma Group International (AAPG)|URGN (urogen.com) - Quarterly Revenue Growth|BCAX: Quarterly Revenue Increase|Revenue Growth QoQ Personalis (PSNL)|Quarterly Revenue Growth Erasca (ERAS)|Quarterly Revenue Growth DCTH (Delcath Systems)|Quarterly Revenue Increase YMAB|AURA - Revenue Growth QoQ|candeltx.com - Sales Change QoQ|ARAY: Quarterly Revenue Growth|Revenue Dynamics QoQ SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Quarterly Revenue Growth|Quarterly Sales Growth Citius Oncology Inc. (CTOR)|Revenue Growth QoQ TuHURA (HURA)|TARA - Quarterly Revenue Growth Rate|Quarterly Revenue Growth FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Quarterly Revenue Growth Rate|TScan - Quarterly Revenue Growth|Champions Oncology, Inc. (CSBR) - Quarterly Sales Growth|XBIT (XBiotech Inc.) - Quarterly Sales Growth|CEL-SCI Corporation (CVM) - Quarterly Revenue Growth|Revenue Growth QoQ OS Therapies|RADX: Quarterly Revenue Increase|Revenue Growth QoQ artivabio.com (ARTV)|Quarterly Sales Growth Rate Adlai Nortye|Quarterly Revenue Growth VERU (Veru Corporation)|Sales Change QoQ TPST (Tempest Tx)|XLO: Quarterly Sales Growth|renovarobio.com (RENB) - Quarterly Sales Growth|Mural Bio (MURA) - Revenue Growth QoQ|Kairos Pharma Inc (KAPA) - Quarterly Revenue Growth|Quarterly Sales Growth OKUR|CytoMed Therapeutics (GDTC) - Quarterly Sales Growth Rate|Quarterly Sales Growth CRIS (Curis Inc.)|Quarterly Revenue Growth Apollomics Inc. (APLM)|Revenue Growth QoQ Tharimmune Corp THAR|Advanced Biomed Corp - Revenue Growth QoQ|GNPX: Quarterly Sales Growth|Calidi Biotherapeutics, Inc. (CLDI) - Quarterly Sales Growth|SBFM: Quarterly Revenue Growth|Quarterly Sales Growth Xenetic Biosciences Inc.|Revenue Growth QoQ Salarius Pharmaceuticals Inc|PPBT: Quarterly Revenue Increase|Quarterly Revenue Growth AONC|BGNE (BeOne Medicines) - Quarterly Revenue Increase|Checkpoint Therapeutics, Inc - Quarterly Sales Growth|elevationoncology.com (ELEV) - Quarterly Revenue Growth Rate|iCAD Inc. - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Ikena Oncology|NTBL: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Viracta (VIRX)|MOR (MorphoSys AG) - Quarterly Revenue Growth|NAYA: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)